Mereo BioPharma Group PLC ADR
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | 0 | -304 | -591 | -1 |
EBITDA | -6,989 | -8,446 | -7,786 | -9,815 |
EBIT | -8,751 | -8,377 | -9,869 | |
Net Income | -7,005 | -6,707 | -7,340 | -7,024 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,043 | -4,312 | -7,683 | -7,309 |
Cash | 30,118 | 36,223 | 40,992 | 48,698 |
Basic Shares | 160,712 | 160,361 | 31,826 | 159,989 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $500 | $0 | $10,000 | $1,507 |
Gross Profit | 367 | -1,088 | 7,426 | 1,146 |
EBITDA | -40,474 | -40,795 | -26,056 | -37,874 |
EBIT | -41,623 | -41,883 | -27,117 | -38,763 |
Net Income | -41,878 | -43,253 | -29,466 | -42,220 |
Net Change In Cash | 500 | 0 | 10,000 | 1,507 |
Free Cash Flow | -30,991 | -33,533 | -21,551 | -48,834 |
Cash | 40,992 | 69,802 | 57,421 | 68,182 |
Basic Shares | 159,423 | 147,924 | 131,890 | 22,797 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.01 |
2026-03-31 | -$0.007 |
2025-12-31 | -$0.01 |
2025-09-30 | -$0.01 |